Torrent Pharmaceuticals is recalling 16 batches of losartan potassium tablets from the US market due to an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by the city-based Hetero Labs.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.